News

Sep 29 2014

Prostate Cancer Canada Translational Acceleration Grant awarded to Drs. Rennie, Cherkasov and Tomlinson-Guns

September 26, 2014 - Prostate Cancer Canada today annouced the results of their funding decision in their Translation Acceleration Grant competition TAG2: Novel Therapeutics for Advanced Disease.  This funding is for groups studying novel therapeutics and treatment options for metastatic and castrate-resistant prostate cancer, for  projects aimed at eliminating advanced disease from affected men. Co-lead by Drs.

Read more
Sep 12 2014

BGI and the Vancouver Prostate Centre Announce Partnership to Create Joint Research Laboratory for Advancement of Translational Cancer Research

SHENZHEN, China and VANCOUVER, British Columbia, September 12, 2014 – BGI, the world’s largest genomics organization, based in China, and The Vancouver Prostate Centre (VPC), a global leader in translational research in cancer, today announced the establishment of the BGI-VPC Joint Research Laboratory, a sequencing and translational research facility, to jointly discover and advance basic and translational programs in oncology, including precision oncology.

Read more
Aug 25 2014

New National Health Sciences Accelerator, Accel-Rx Formally Launched as a Centre of Excellence for Commercialization and Research

With the awarding of $14.5M under the Canadian government’s Networks of Centres of Excellence (Centres of Excellence for Commercialization and Research (CECR)) Program, as announced earlier this morning by the Honourable Ed Holder, Minister of State for Science and Technology, Accel-Rx - Canada’s Health Sciences Accelerator is officially launched.The Accel-Rx Health Sciences Accelerator is a national organization focused on maximizing new health sciences company creation, and ensuring start-ups have the resources they need to enable them to stay and grow in Canada and give rise to a new gen

Read more
Jan 23 2014

Funding announced for Dr. Yuzhuo Wang’s next generation prostate cancer research

VANCOUVER – Today the Canadian Institutes of Health Research (CIHR) is announcing it will match funding from BRI Biopharmaceutical Research Inc (BRI) for a total of $750,000 over a three year Industry Partnered Collaborative Research Grant. This money will enable ongoing research collaborations between Dr. Yuzhuo Wang’s laboratories at the BC Cancer Agency and Vancouver Prostate Centre (VPC), and BRI to develop new state-of-the-art experimental cancer models.Read the press release here (91 kb PDF, opens in new window) Dr. Wang, Dr.

Read more
Jan 09 2014

Dr. Gleave to give MSFHR-VCHRI lecture on the PC-TRiADD Model

The Michael Smith Foundation for Health Research (MSFHR) and the Vancouver Coastal Research Institute are pleased to present a lecture by one of British Columbia’s most innovative scientists — a man who has bridged the gap between clinical research and new commercial treatments for disease.   Dr. Martin Gleave is the most recent recipient of the MSFHR Aubrey J.

Read more
Jan 06 2014

Dr. Kim Chi recieves a BC Cancer Agency Clinician Researcher Award

Dr. Kim Chi is one of two recipients of the BC Cancer Agency Clinician Researcher Award, funded by BC Cancer Foundation donors.Selected by their peers from a high calibre of applicants, Dr. Chi and Dr. David W. Scott were awarded a cumulative $1.5 million over five years. Dr. Chi's project will focus on translational research in prostate cancer, while Dr. Scott will further investigate treatment failure in B cell lymphoid cancers.

Read more
Oct 15 2013

Dr. Martin Gleave awarded fourth annual Aubrey J. Tingle Prize

Dr. Martin Gleave, chief executive officer of PC-TRiADD, is the winner of the fourth annual Aubrey J. Tingle Prize.  Created in honour of the Michael Smith Foundation for Health Research's founding president and CEO, this award is given to a British Columbia researcher whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research.“Martin has contributed significantly to the understanding and treatment of prostate cancer, a disease that affects thousands of Canadian men every year,” says Dr.

Read more

Pages

News

Sep 29 2014

Prostate Cancer Canada Translational Acceleration Grant awarded to Drs. Rennie, Cherkasov and Tomlinson-Guns

September 26, 2014 - Prostate Cancer Canada today annouced the results of their funding decision in their Translation Acceleration Grant competition TAG2: Novel Therapeutics for Advanced Disease.  This funding is for groups studying novel therapeutics and treatment options for metastatic and castrate-resistant prostate cancer, for  projects aimed at eliminating advanced disease from affected men. Co-lead by Drs.

Read more
Sep 12 2014

BGI and the Vancouver Prostate Centre Announce Partnership to Create Joint Research Laboratory for Advancement of Translational Cancer Research

SHENZHEN, China and VANCOUVER, British Columbia, September 12, 2014 – BGI, the world’s largest genomics organization, based in China, and The Vancouver Prostate Centre (VPC), a global leader in translational research in cancer, today announced the establishment of the BGI-VPC Joint Research Laboratory, a sequencing and translational research facility, to jointly discover and advance basic and translational programs in oncology, including precision oncology.

Read more
Aug 25 2014

New National Health Sciences Accelerator, Accel-Rx Formally Launched as a Centre of Excellence for Commercialization and Research

With the awarding of $14.5M under the Canadian government’s Networks of Centres of Excellence (Centres of Excellence for Commercialization and Research (CECR)) Program, as announced earlier this morning by the Honourable Ed Holder, Minister of State for Science and Technology, Accel-Rx - Canada’s Health Sciences Accelerator is officially launched.The Accel-Rx Health Sciences Accelerator is a national organization focused on maximizing new health sciences company creation, and ensuring start-ups have the resources they need to enable them to stay and grow in Canada and give rise to a new gen

Read more